Remidio

Remidio We are driven by innovation to design simple solutions to eradicate preventable blindness!

Founded by professionals with a passion for product innovation, Remidio is currently focussed on creating game changing products and solutions in the ophthalmology space. We look at constraints posed by a developing nation context- infrastructure, skilled resources and affordable pricing as an opportunity to innovate. We bring to market very high quality products that are reliable and extremely simple to use.

28/01/2026

Anusha Purushotham, Head of Health Systems & Policy at Remidio, is speaking today at the Health of India (HOI) Summit 2026. In the session “AI Innovators on Breaking New Ground,” she will discuss how AI-driven, portable technologies can be embedded into health systems to enable early detection of retinal and chronic diseases and help prevent avoidable blindness at scale.

Join us at the conversation shaping the future of AI and health systems in India.

India’s progress is powered by clear insight.This Republic Day, we reflect on the values that define our nation: integri...
26/01/2026

India’s progress is powered by clear insight.

This Republic Day, we reflect on the values that define our nation: integrity, inclusivity, and responsibility. Just as the Constitution guides India’s journey forward, insight and foresight help us protect what matters most, the health and well-being of our people. At Remidio, we believe the eye is not just for vision, it is a window to health.

Here’s to a healthier, stronger nation.

Happy Republic Day.

The New Indian Express features how AI is enabling accurate, large-scale diabetic eye screening in real-world settings.T...
25/01/2026

The New Indian Express features how AI is enabling accurate, large-scale diabetic eye screening in real-world settings.

The article highlights evidence from a large population study published in The Lancet, demonstrating that AI systems can reliably support early detection of diabetic retinopathy—helping extend specialist-grade screening into primary care and community health programs.

At Remidio, this reflects our focus on building clinically validated AI that works at scale, where access and impact matter most.

Read the full article
https://zurl.co/Anzo0

CHENNAI: Mass diabetic retinopathy screening with high predictive accuracy could soon become a reality in high-burden countries such as India, eliminating the n

Preeclampsia is one of the leading risks in pregnancy, often developing quietly while impacting multiple systems in the ...
23/01/2026

Preeclampsia is one of the leading risks in pregnancy, often developing quietly while impacting multiple systems in the body.

Early visibility into risk can make a critical difference. Simple retinal screening, when included in routine care, can help clinicians act sooner and support safer pregnancies.

On this Maternal Health Day, we’re reminded that protecting mothers means protecting the future.

22/01/2026

Beyond Clinics, Taking Eye Care Where Patients Are

In this YOSI-hosted webinar, Dr. Prasanna V. Ramesh and other eminent speakers discuss how eye care can move beyond hospitals and clinics into communities and homes.

See how portable retinal imaging is making large-scale, practical eye care delivery possible.
Watch the full webinar recording on YouTube .
https://zurl.co/76cwH

20/01/2026

Watch Dr. Jitendra Jethani share his clinical experience with OBM and how one seamless scan delivering complete myopia intelligence has enhanced precision, efficiency, confidence, and proactive management of myopia progression in everyday practice.

16/01/2026

One Scan. Total Myopia Intelligence.

Precision meets automation for proactive myopia care.

One seamless scan captures 12 critical eye parameters, unifying biometric and refractive data in a single all-in-one clinical workflow.

14/01/2026

Every harvest is precious. Every beginning is delicate. Everything you build deserves care.

This festive season, as we celebrate Pongal, Lohri and Makar Sankranti, may all that you build stay blessed, watched over, and may the evil eye never touch it.

Wishing you abundance, warmth and well-being.

Curiosity and courage set every journey in motion. Our GTP 2.0 selection drive at KIT – Kalaignarkarunanidhi Institute o...
13/01/2026

Curiosity and courage set every journey in motion. Our GTP 2.0 selection drive at KIT – Kalaignarkarunanidhi Institute of Technology brought together driven students eager to learn, grow, and take on real-world challenges.

The Graduate Trainee Program (GTP) is designed to give young talent early exposure, real ownership, and hands-on learning, helping them build strong foundations while contributing meaningfully from day one. With GTP 2.0, the focus is on expanding this vision and nurturing future leaders who grow with Remidio.

Grateful to the KIT team for the warm welcome and seamless coordination.
Here’s to growing talent and scaling purpose.

January marks Glaucoma Awareness Month.Glaucoma often develops silently, without pain or early warning signs. Many peopl...
08/01/2026

January marks Glaucoma Awareness Month.
Glaucoma often develops silently, without pain or early warning signs. Many people only realise something is wrong after permanent vision loss has already occurred, affecting independence, work, and everyday life.

Yet vision loss from glaucoma can often be slowed or prevented. Early detection through regular eye examinations enables timely treatment and helps protect long term sight.

This month, encourage those you care about to prioritise their eye health. A simple eye examination can help prevent avoidable blindness and safeguard a brighter future.

Dr. Anand Sivaraman spoke at the Responsible AI for Synergistic Excellence (RAISE) Convening, organized by the WHO South...
06/01/2026

Dr. Anand Sivaraman spoke at the Responsible AI for Synergistic Excellence (RAISE) Convening, organized by the WHO South-East Asia Regional Office in collaboration with the Koita Center for Digital Health at Ashoka University.

RAISE brings together leaders and policymakers to advance dialogue on AI governance, innovation, and responsible adoption, ahead of the India-AI Impact Summit 2026.

The session focused on learnings from real-world, population-scale AI deployments and explored how thoughtful policy and governance frameworks can enable responsible, impactful, and scalable AI—especially in healthcare.

Grateful for the opportunity to contribute to shaping AI in the public interest.

This World Braille Day, we recognize the power of accessibility to change lives. At Remidio, our mission is rooted in in...
04/01/2026

This World Braille Day, we recognize the power of accessibility to change lives. At Remidio, our mission is rooted in inclusion, advancing eye care solutions that ensure no one is left behind.

Address

No, 1-51-2/12, Vacuum Techniques Compound, 1st Cross Road, Peenya Industrial Area, Phase-I
Bangalore
560058

Opening Hours

Monday 9:30am - 6:30pm
Tuesday 9:30am - 6:30pm
Wednesday 9:30am - 6:30pm
Thursday 9:30am - 6:30pm
Friday 9:30am - 6:30pm

Telephone

+919019022285

Alerts

Be the first to know and let us send you an email when Remidio posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Contact The Practice

Send a message to Remidio:

Share

Share on Facebook Share on Twitter Share on LinkedIn
Share on Pinterest Share on Reddit Share via Email
Share on WhatsApp Share on Instagram Share on Telegram

Our Story

Presenting few interesting, one of a kind in the world technologies like Offline Artificial Intelligence for the detection of Diabetic Retinopathy, Portable HFA on a VR headset, Universal Slit Lamp Imager at the ESCRS. Come visit us.